Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Class A Common Stock, $0.01 par value per share
-
Shares outstanding
-
42M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
24.5M
-
Shares change
-
+350K
-
Total reported value, excl. options
-
$27.7M
-
Value change
-
-$72K
-
Number of buys
-
16
-
Number of sells
-
-23
-
Price
-
$1.13
Significant Holders of RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share (RPID) as of Q4 2022
51 filings reported holding RPID - RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share as of Q4 2022.
RAPID MICRO BIOSYSTEMS, INC. - Class A Common Stock, $0.01 par value per share (RPID) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.5M shares
of 42M outstanding shares and own 58.31% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (8.43M shares), KENNEDY LEWIS MANAGEMENT LP (4.94M shares), T. Rowe Price Investment Management, Inc. (2.19M shares), ABG-WTT Global Life Science Capital Partners GP Ltd (1.04M shares), GOLDMAN SACHS GROUP INC (1.03M shares), BlackRock Inc. (1.03M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (810K shares), PRICE T ROWE ASSOCIATES INC /MD/ (801K shares), VANGUARD GROUP INC (730K shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (716K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.